EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Effectiveness of Intranasal Corticosteroids for Sleep Disturbances in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis

Kenshiro Tabata, Yukiyoshi Sumi, Hatoko Sasaki, Noriko Kojimahara

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000541389 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Kenshiro Tabata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Rhinitis, Allergic, Sleep Wake Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allergic rhinitis (AR) is a chronic condition caused by an immunoglobulin E-mediated response to environmental allergens, which affects 10–40% of the global population. AR symptoms, such as nasal congestion and rhinorrhea, significantly reduce quality of life and are associated with sleep disturbances, further exacerbating the condition’s burden. Despite the known impact of AR on sleep, the effects of intranasal corticosteroids on sleep quality have not been comprehensively reviewed. Therefore, this systematic review and meta-analysis aimed to investigate the efficacy of intranasal corticosteroids in improving sleep quality among patients with AR.

Methods

This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The study protocol was registered with PROSPERO (CRD42023460698). A comprehensive search was conducted on PubMed, Cochrane Central Register of Controlled Trials, and Ichushi-Web. Randomized controlled trials (RCTs) comparing intranasal corticosteroids with placebos in patients with AR were included. Data extraction and risk of bias assessment were independently performed by two authors. The primary outcome was the improvement in sleep quality measured by standardized questionnaires. Meta-analyses were performed using a random-effects model. The risk of bias was assessed using the RoB2 tool.

Results

Eighteen RCTs involving 6,019 participants were included. The meta-analysis of 12 comparisons from eight studies for the Rhinoconjunctivitis Quality of Life Questionnaire sleep domain showed significant improvement in sleep quality with a standardized mean difference (SMD) of 0.292 (95% confidence interval [CI]: 0.235–0.350, p < 0.0001, I2 = 0.0%). The Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire also showed improvement with an SMD of 0.284 (95% CI: 0.164–0.404, p < 0.0001) based on two comparisons from one study. However, the Epworth Sleepiness Scale did not show significant results (SMD: 0.027, 95% CI: −0.429 to 0.483, p = 0.907) based on two comparisons from two studies. Sensitivity analysis, excluding two studies with high risk of bias according to RoB2, confirmed the robustness of these results. Subgroup analyses for patients with seasonal or perennial AR showed significant improvements in both groups.

Conclusion

This study demonstrates that intranasal corticosteroids significantly improve sleep quality in patients with AR. These findings support the use of intranasal corticosteroids as a first-line treatment for AR, not only for managing daytime symptoms but also for enhancing sleep quality. Future research should focus on sleep quality changes as a primary outcome and incorporate both subjective and objective measures to better understand the relationship between sleep and AR symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesRhinitis, AllergicSleep Wake DisordersHumansAdministration, IntranasalTreatment OutcomeQuality of LifeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Allergic rhinitisIntranasal corticosteroidsMeta-analysisSleep disturbanceSystematic review

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Department of Psychiatry, Shiga University of Medical Science, Otsu, Japan.
  • Department of Psychiatry, Nagahama Red Cross Hospital, Nagahama, Japan.
  • Section of Epidemiology, Shizuoka Graduate University of Public Health, Shizuoka, Japan.

Zitieren

APA

Tabata, K., Sumi, Y., Sasaki, H., & Kojimahara, N. (2024). Effectiveness of Intranasal Corticosteroids for Sleep Disturbances in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis. International Archives of Allergy and Immunology. https://doi.org/10.1159/000541389

Vancouver

Tabata K, Sumi Y, Sasaki H, Kojimahara N. Effectiveness of Intranasal Corticosteroids for Sleep Disturbances in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis. International Archives of Allergy and Immunology. 2024. doi:10.1159/000541389

BibTeX
@article{Tabata2024,
  author = {Tabata, Kenshiro and Sumi, Yukiyoshi and Sasaki, Hatoko and Kojimahara, Noriko},
  title = {Effectiveness of Intranasal Corticosteroids for Sleep Disturbances in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000541389}
}
Kostenlos starten →